Daoud Sheban

1.1k total citations
6 papers, 145 citations indexed

About

Daoud Sheban is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Daoud Sheban has authored 6 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Daoud Sheban's work include Ubiquitin and proteasome pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers) and interferon and immune responses (2 papers). Daoud Sheban is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers) and interferon and immune responses (2 papers). Daoud Sheban collaborates with scholars based in Israel and United States. Daoud Sheban's co-authors include Bluma Berman, Shachar Raz, Yehuda G. Assaraf, Michal Stark, Nitzan Gonen, Yifat Merbl, Avital Eisenberg‐Lerner, Merav D. Shmueli, Bernardo Oldak and Jonathan Bayerl and has published in prestigious journals such as Nature Biotechnology, Journal of Molecular Biology and Cell Death and Differentiation.

In The Last Decade

Daoud Sheban

6 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daoud Sheban Israel 5 105 31 26 24 14 6 145
Kärt Tomberg United States 8 106 1.0× 15 0.5× 19 0.7× 12 0.5× 7 0.5× 12 196
Eduardo Zarzuela Spain 10 164 1.6× 28 0.9× 11 0.4× 28 1.2× 10 0.7× 15 202
Yifat Geffen United States 6 143 1.4× 23 0.7× 21 0.8× 54 2.3× 23 1.6× 10 184
Insha Mushtaq United States 9 90 0.9× 30 1.0× 20 0.8× 36 1.5× 5 0.4× 12 147
Jingyi Li China 7 110 1.0× 17 0.5× 64 2.5× 18 0.8× 11 0.8× 29 216
Q. Zhang United States 5 117 1.1× 52 1.7× 33 1.3× 13 0.5× 15 1.1× 13 165
Katja Apelt Netherlands 8 255 2.4× 45 1.5× 19 0.7× 15 0.6× 5 0.4× 10 287
Maria Notaridou United Kingdom 4 108 1.0× 68 2.2× 24 0.9× 23 1.0× 6 0.4× 5 162
Keith Booher United States 7 75 0.7× 30 1.0× 42 1.6× 7 0.3× 4 0.3× 11 141
Stanimir Dulev United States 7 344 3.3× 21 0.7× 20 0.8× 65 2.7× 10 0.7× 9 363

Countries citing papers authored by Daoud Sheban

Since Specialization
Citations

This map shows the geographic impact of Daoud Sheban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoud Sheban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoud Sheban more than expected).

Fields of papers citing papers by Daoud Sheban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daoud Sheban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoud Sheban. The network helps show where Daoud Sheban may publish in the future.

Co-authorship network of co-authors of Daoud Sheban

This figure shows the co-authorship network connecting the top 25 collaborators of Daoud Sheban. A scholar is included among the top collaborators of Daoud Sheban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daoud Sheban. Daoud Sheban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Sheban, Daoud & Yifat Merbl. (2023). EMSY stabilization in KEAP1-mutant lung cancer disrupts genome stability and type I interferon signaling. Cell Death and Differentiation. 30(5). 1397–1399. 3 indexed citations
2.
Viukov, Sergey, Tom Shani, Jonathan Bayerl, et al.. (2022). Human primed and naïve PSCs are both able to differentiate into trophoblast stem cells. Stem Cell Reports. 17(11). 2484–2500. 33 indexed citations
3.
Ulman, Adi, Bareket Dassa, Aaron Javitt, et al.. (2021). Altered Protein Abundance and Localization Inferred from Sites of Alternative Modification by Ubiquitin and SUMO. Journal of Molecular Biology. 433(21). 167219–167219. 5 indexed citations
4.
Shmueli, Merav D., Daoud Sheban, Avital Eisenberg‐Lerner, & Yifat Merbl. (2021). Histone degradation by the proteasome regulates chromatin and cellular plasticity. FEBS Journal. 289(12). 3304–3316. 15 indexed citations
5.
Javitt, Aaron, Avital Eisenberg‐Lerner, Assaf Kacen, et al.. (2018). Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides. Nature Biotechnology. 36(11). 1110–1116. 33 indexed citations
6.
Raz, Shachar, Daoud Sheban, Nitzan Gonen, et al.. (2014). Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest. Cell Death and Disease. 5(2). e1067–e1067. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026